The current landscape of imaging recommendations in cardiovascular clinical guidelines: toward an imaging-guided precision medicine

Abstract

The purpose of this article is to provide an overview on the role of CT scan and MRI according to selected guidelines by the European Society of Cardiology (ESC) and the American College of Cardiology/American Heart Association (ACC/AHA). ESC and ACC/AHA guidelines were systematically reviewed for recommendations to CT and MRI use in specific cardiovascular (CV) clinical categories. All recommendations were collected in a dataset, including the class of recommendation, the level of evidence (LOE), the specific imaging technique, the clinical purpose of the recommendation and the recommending Society. Among the 43 included guidelines (ESC: n = 18, ACC/AHA: n = 25), 26 (60.4%) contained recommendations for CT scan or MRI (146 recommendations: 62 for CT and 84 for MRI). Class of recommendation IIa (32.9%) was the most represented, followed by I (28.1%), IIb (24%) and III (11.9%). MRI recommendations more frequently being of higher class (I: 36.9%, IIa: 29.8%, IIb: 21.4%, III: 11.9%) as compared to CT (I: 16.1%, IIa: 37.1%, IIb: 27.4%, III: 19.4%). Most of recommendation (55.5%) were based on expert opinion (LOE C). The use of cardiac CT and cardiac MR in the risk assessment, diagnosis, therapeutic and procedural planning is in continuous development, driven by an increasing need to evolve toward an imaging-guided precision medicine, combined with cost-effectiveness and healthcare sustainability. These developments must be accompanied by an increased availability of high-performance scanners in healthcare facilities and should emphasize the need of increasing the number of radiologists fully trained in cardiac imaging.

Advanced cardiac imaging in athlete’s heart: unravelling the grey zone between physiologic adaptation and pathology

“…The value of advanced cardiac imaging is established in current guidelines [ 8 , 9 ]. In fact, for inconclusive echocardiography or in suspected cases of coronary abnormalities or cardiomyopathies, coronary computed tomography angiography (CCTA) and cardiac magnetic resonance (CMR) are indicated [ 8 , 10 ].…”

SIRM–SIC appropriateness criteria for the use of Cardiac Computed Tomography. Part 1: Congenital heart diseases, primary prevention, risk assessment before surgery, suspected CAD in symptomatic patients, plaque and epicardial adipose tissue characterization, and functional assessment of stenosis

“…In this complex and revolutionary scenario, in which guidelines help the translation of evidences into clinical practice [8], there is a clear need of updating the previously published documents on appropriateness for clinical/practical use of CCT [9][10][11][12].…”

The Radiologist as a Gatekeeper in Chest Pain

“…Over the years, the role of CCTA has grown exponentially as it allows for plaque characterization and the visualization of the anatomy of the coronary and extra-cardiac structures [ 54 , 57 , 58 , 59 , 60 ]. Furthermore, CCTA is able to detect other life-threatening non-cardiac causes of chest pain such as acute aortic dissection (AAS) and PE [ 6 , 15 , 38 , 61 ].…”